Search research articles
Contact Us
Filters
Showing results (21-30 of 52) with videos related to
Page
of 6
Sort By:
Archives of Osteoporosis
|
December 9, 2022
Impaired postural control in diabetes-a predictor of falls?
Nicklas Højgaard-Hessellund Rasmussen, Jakob Dal, Morten Hasselstrøm Jensen, et al.
Pituitary
|
March 14, 2025
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature
Astrid Thaarup Matthesen, Christian Rosendal, Emma H Christensen, et al.
Pituitary
|
August 1, 2024
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
Erlend Gjersdal, Liva Bundgaard Larsen, Kåre Schmidt Ettrup, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 28, 2020
Disease Control and Gender Predict the Socioeconomic Effects of Acromegaly: A Nationwide Cohort Study
Jakob Dal, Eigil H Nielsen, Ulla-Feldt Rasmussen, et al.
European Journal of Endocrinology
|
January 18, 2023
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment
Mai C Arlien-Søborg, Michael Alle Madsen, Jakob Dal, et al.
European Journal of Endocrinology
|
December 17, 2025
Rising burden of PRL-PitNETs: patterns across tumour sizes and incidentalomas
Frederik Østergaard Klit, Sara Faartoft Nørgård, Anna-Sofie Dam Berrett, et al.
European Journal of Endocrinology
|
October 11, 2017
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Jakob Dal, Marianne Klose, Ansgar Heck, et al.
Acta Neuropsychiatrica
|
June 5, 2025
Gender-affirming hormone therapy, quality of life, and the role of oestradiol and testosterone in transgender individuals
Emma Elisabeth Skovby Petersen, Frederika Kiy, Ulrik Schiøler Kesmodel, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 29, 2016
Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment
Jakob Dal, Katrine Lundby Høyer, Steen Bønløkke Pedersen, et al.
Pituitary
|
August 20, 2025
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life
Erlend Gjersdal, Frederik Østergaard Klit, Kåre Schmidt Ettrup, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 52) with videos related to
Sort By:
Page
of 6
Archives of Osteoporosis
|
December 9, 2022
Impaired postural control in diabetes-a predictor of falls?
Nicklas Højgaard-Hessellund Rasmussen, Jakob Dal, Morten Hasselstrøm Jensen, et al.
Pituitary
|
March 14, 2025
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature
Astrid Thaarup Matthesen, Christian Rosendal, Emma H Christensen, et al.
Pituitary
|
August 1, 2024
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
Erlend Gjersdal, Liva Bundgaard Larsen, Kåre Schmidt Ettrup, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 28, 2020
Disease Control and Gender Predict the Socioeconomic Effects of Acromegaly: A Nationwide Cohort Study
Jakob Dal, Eigil H Nielsen, Ulla-Feldt Rasmussen, et al.
European Journal of Endocrinology
|
January 18, 2023
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment
Mai C Arlien-Søborg, Michael Alle Madsen, Jakob Dal, et al.
European Journal of Endocrinology
|
December 17, 2025
Rising burden of PRL-PitNETs: patterns across tumour sizes and incidentalomas
Frederik Østergaard Klit, Sara Faartoft Nørgård, Anna-Sofie Dam Berrett, et al.
European Journal of Endocrinology
|
October 11, 2017
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Jakob Dal, Marianne Klose, Ansgar Heck, et al.
Acta Neuropsychiatrica
|
June 5, 2025
Gender-affirming hormone therapy, quality of life, and the role of oestradiol and testosterone in transgender individuals
Emma Elisabeth Skovby Petersen, Frederika Kiy, Ulrik Schiøler Kesmodel, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 29, 2016
Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment
Jakob Dal, Katrine Lundby Høyer, Steen Bønløkke Pedersen, et al.
Pituitary
|
August 20, 2025
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life
Erlend Gjersdal, Frederik Østergaard Klit, Kåre Schmidt Ettrup, et al.
Page
of 6